"My own thinking is if results from the stage 2 of the pivotal trial are excellent then a commercial distribution partnership will follow in the months after that announcement"
While it is possible, I would think it unlikely given the endpoints of the pre-validation stage are only hardware verification and AI finessing. I think it more likely that distribution agreements will follow the results of the validation phase i.e. after specificity and sensitivity outcomes are known.
EMvision Research Notes, page-2320
-
- There are more pages in this discussion • 435 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
-0.065(3.25%) |
Mkt cap ! $168.4M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.00 | $1.94 | $102.8K | 52.37K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150 | $1.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.94 | 152 | 1 |
View Market Depth
| Last trade - 15.29pm 13/11/2024 (20 minute delay) ? |
| EMV (ASX) Chart |